NO770619L - Fremgangsm}te for fremstilling av 2,3-substituerte-5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning - Google Patents

Fremgangsm}te for fremstilling av 2,3-substituerte-5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning

Info

Publication number
NO770619L
NO770619L NO770619A NO770619A NO770619L NO 770619 L NO770619 L NO 770619L NO 770619 A NO770619 A NO 770619A NO 770619 A NO770619 A NO 770619A NO 770619 L NO770619 L NO 770619L
Authority
NO
Norway
Prior art keywords
pyranons
aminoalcoxy
ischaemia
hypotensive
condensed
Prior art date
Application number
NO770619A
Other languages
English (en)
Other versions
NO145841B (no
NO145841C (no
Inventor
Philippe Briet
Jean-Jacques Berthelon
Jean-Claude Depin
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO770619L publication Critical patent/NO770619L/no
Publication of NO145841B publication Critical patent/NO145841B/no
Publication of NO145841C publication Critical patent/NO145841C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
NO770619A 1976-02-25 1977-02-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3-substituerte, 5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning NO145841C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7605234A FR2368952A1 (fr) 1976-02-25 1976-02-25 Nouveaux aminoalcoxy-4 (2 h) pyranone-2,3 substitues-5,6 condenses

Publications (3)

Publication Number Publication Date
NO770619L true NO770619L (no) 1977-08-26
NO145841B NO145841B (no) 1982-03-01
NO145841C NO145841C (no) 1982-06-09

Family

ID=9169581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770619A NO145841C (no) 1976-02-25 1977-02-24 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3-substituerte, 5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning

Country Status (24)

Country Link
US (1) US4230850A (no)
JP (1) JPS52122371A (no)
AR (1) AR218444A1 (no)
AT (1) AT352720B (no)
AU (1) AU510619B2 (no)
BE (1) BE850522A (no)
CA (1) CA1092112A (no)
CH (1) CH620918A5 (no)
CS (1) CS195325B2 (no)
DE (1) DE2707746A1 (no)
DK (1) DK80777A (no)
ES (1) ES456243A1 (no)
FR (1) FR2368952A1 (no)
GB (1) GB1566491A (no)
HU (1) HU178275B (no)
IE (1) IE44489B1 (no)
IL (1) IL51428A (no)
MX (1) MX4161E (no)
NL (1) NL7702090A (no)
NO (1) NO145841C (no)
SE (1) SE7702041L (no)
SU (1) SU638259A3 (no)
YU (1) YU44977A (no)
ZA (1) ZA77741B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368952A1 (fr) 1976-02-25 1978-05-26 Lipha Nouveaux aminoalcoxy-4 (2 h) pyranone-2,3 substitues-5,6 condenses
US4259327A (en) 1979-04-02 1981-03-31 Merck & Co., Inc. Substituted aminoalkoxypyridines, compositions and use thereof
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
PL187175B1 (pl) * 1995-10-13 2004-05-31 Bayer Cropscience Ltd Bicykliczne związki heterocykliczne, kompozycja grzybobójcza je zawierająca i ich zastosowanie
DE10030094A1 (de) * 2000-06-19 2001-12-20 Bayer Ag Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
US7538233B2 (en) 2003-09-05 2009-05-26 Aventis Pharmaceuticals Inc. Coumarins as iNOS inhibitors
EP3133065A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
EP3133066A1 (en) * 2015-08-21 2017-02-22 Merck Patent GmbH Hydrophilic compounds for optically active devices
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
CN111620848A (zh) * 2020-04-29 2020-09-04 华东师范大学 含吡喃和中环骨架的三环稠合芳香体系化合物及其合成和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368952A1 (fr) 1976-02-25 1978-05-26 Lipha Nouveaux aminoalcoxy-4 (2 h) pyranone-2,3 substitues-5,6 condenses

Also Published As

Publication number Publication date
IL51428A (en) 1981-06-29
AU510619B2 (en) 1980-07-03
FR2368952B1 (no) 1980-04-30
SE7702041L (sv) 1977-08-26
AT352720B (de) 1979-10-10
FR2368952A1 (fr) 1978-05-26
ATA126277A (de) 1979-03-15
CS195325B2 (en) 1980-01-31
SU638259A3 (ru) 1978-12-15
MX4161E (es) 1982-01-14
IL51428A0 (en) 1977-04-29
JPS52122371A (en) 1977-10-14
IE44489L (en) 1977-08-25
AU2255677A (en) 1978-08-31
AR218444A1 (es) 1980-06-13
NL7702090A (nl) 1977-08-29
YU44977A (en) 1982-06-30
HU178275B (en) 1982-04-28
IE44489B1 (en) 1981-12-16
CH620918A5 (no) 1980-12-31
DE2707746A1 (de) 1977-09-01
NO145841B (no) 1982-03-01
US4230850A (en) 1980-10-28
BE850522A (fr) 1977-07-19
ZA77741B (en) 1977-12-28
ES456243A1 (es) 1978-01-16
CA1092112A (en) 1980-12-23
DK80777A (da) 1977-08-26
NO145841C (no) 1982-06-09
GB1566491A (en) 1980-04-30

Similar Documents

Publication Publication Date Title
NO772345L (no) Fremgangsm}te til fremstilling av ren metyl-terti{r-butyleter
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO149883C (no) Fremgangsmaate for fremstilling av hydrogenperoksyd
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO770619L (no) Fremgangsm}te for fremstilling av 2,3-substituerte-5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
PL199723A1 (pl) Sposob wytwarzania n-/1'-allilo-2'-metylopirolidylo//-2,3-dwumetoksy-5-sulfamylobenzamidu i jego pochodnych
JPS57136577A (en) Manufacture of 2,4-diamino-5-benzylpyrimidine
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
NO772809L (no) Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol